{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T16:39:37Z","timestamp":1793637577628,"version":"4.5.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672623"],"award-info":[{"award-number":["81672623"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019065","name":"Tianjin Science and Technology Program","doi-asserted-by":"publisher","award":["19YFZCSY0030"],"award-info":[{"award-number":["19YFZCSY0030"]}],"id":[{"id":"10.13039\/501100019065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Family history is a major risk factor for breast cancer; approximately 5\u201310% cases of breast cancer are associated with a family history. Herein, we investigated the link between family history and breast cancer features to elucidate the importance of family history in the diagnosis and treatment of breast cancer. Data from 10,549 patients with breast cancer were collected from 2014 to 2017. Detailed information about the family history of the patients including the degree and number of relatives affected and the types of cancer was recorded. The tumors were pathologically and clinically classified based on the stage, grade, ER, PR, HER2, Ki-67 status, and subtypes, according to standard guidelines. Data were analyzed using \u03c7\n                    <jats:sup>2<\/jats:sup>\n                    test and multiple logistic regression. Patients with a family history of other cancer types were significantly older at diagnosis than patients with a family history of breast\/ovarian cancer (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.002) and those without a family history of cancer (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001). Patients without a family history of cancer were typically diagnosed at a later stage, including high frequency in N2 (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.035) and TNM stage III (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.015). Compared with patients with second-\/third-degree relatives, those with first-degree relatives having breast\/ovarian cancer had a higher median age (54.1,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001) at diagnosis and showed more advanced disease. No significant difference was found between ER, PR, and HER2 status in patients with and without a family history of cancer. Family history of breast cancer can influence the cancer characteristics of the patients at diagnosis, especially patient age, tumor stage, and grade.\n                  <\/jats:p>","DOI":"10.1038\/s41598-021-85899-8","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T12:47:41Z","timestamp":1616071661000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Correlation between family history and characteristics of breast cancer"],"prefix":"10.1038","volume":"11","author":[{"given":"Lei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomeng","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zian","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangcheng","family":"Zhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,18]]},"reference":[{"key":"85899_CR1","unstructured":"Organization, W. H. Latest global cancer data: Cancer burden rises to 18.1 million new cases and 9.6 million cancer deaths in 2018. International Agency for Research on Cancer (2018)."},{"key":"85899_CR2","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1002\/cncr.22193","volume":"107","author":"HL Howe","year":"2006","unstructured":"Howe, H. L. et al. Annual report to the nation on the status of cancer, 1975\u20132003, featuring cancer among US Hispanic\/Latino populations. Cancer 107, 1711\u20131742. https:\/\/doi.org\/10.1002\/cncr.22193 (2006).","journal-title":"Cancer"},{"key":"85899_CR3","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1001\/jamaoncol.2016.6326","volume":"3","author":"NJ Engmann","year":"2017","unstructured":"Engmann, N. J. et al. Population-attributable risk proportion of clinical risk factors for breast cancer. JAMA Oncol. 3, 1228\u20131236. https:\/\/doi.org\/10.1001\/jamaoncol.2016.6326 (2017).","journal-title":"JAMA Oncol."},{"key":"85899_CR4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s10549-017-4325-2","volume":"165","author":"HR Brewer","year":"2017","unstructured":"Brewer, H. R., Jones, M. E., Schoemaker, M. J., Ashworth, A. & Swerdlow, A. J. Family history and risk of breast cancer: An analysis accounting for family structure. Breast Cancer Res. Treat. 165, 193\u2013200. https:\/\/doi.org\/10.1007\/s10549-017-4325-2 (2017).","journal-title":"Breast Cancer Res. Treat."},{"key":"85899_CR5","doi-asserted-by":"publisher","first-page":"R31","DOI":"10.1530\/JME-14-0252","volume":"54","author":"CH Diep","year":"2015","unstructured":"Diep, C. H., Daniel, A. R., Mauro, L. J., Knutson, T. P. & Lange, C. A. Progesterone action in breast, uterine, and ovarian cancers. J. Mol. Endocrinol. 54, R31-53. https:\/\/doi.org\/10.1530\/JME-14-0252 (2015).","journal-title":"J. Mol. Endocrinol."},{"key":"85899_CR6","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"85899_CR7","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1200\/JCO.2015.63.7454","volume":"34","author":"ER Thompson","year":"2016","unstructured":"Thompson, E. R. et al. Panel testing for familial breast cancer: Calibrating the tension between research and clinical care. J. Clin. Oncol. 34, 1455\u20131459. https:\/\/doi.org\/10.1200\/JCO.2015.63.7454 (2016).","journal-title":"J. Clin. Oncol."},{"key":"85899_CR8","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/cncr.29041","volume":"121","author":"J Mersch","year":"2015","unstructured":"Mersch, J. et al. Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian. Cancer 121, 269\u2013275. https:\/\/doi.org\/10.1002\/cncr.29041 (2015).","journal-title":"Cancer"},{"key":"85899_CR9","doi-asserted-by":"publisher","first-page":"32043","DOI":"10.18632\/oncotarget.16761","volume":"8","author":"S Li","year":"2017","unstructured":"Li, S. et al. Loss of PTEN expression in breast cancer: Association with clinicopathological characteristics and prognosis. Oncotarget 8, 32043\u201332054. https:\/\/doi.org\/10.18632\/oncotarget.16761 (2017).","journal-title":"Oncotarget"},{"key":"85899_CR10","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1158\/1535-7163.MCT-15-0945","volume":"15","author":"M Choi","year":"2016","unstructured":"Choi, M., Kipps, T. & Kurzrock, R. ATM mutations in cancer: Therapeutic implications. Mol. Cancer Ther. 15, 1781\u20131791. https:\/\/doi.org\/10.1158\/1535-7163.MCT-15-0945 (2016).","journal-title":"Mol. Cancer Ther."},{"key":"85899_CR11","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.6004\/jnccn.2018.0083","volume":"16","author":"TB Bevers","year":"2018","unstructured":"Bevers, T. B. et al. Breast cancer screening and diagnosis, version 3.2018, NCCN clinical practice guidelines in oncology. J. Natl. Compr. Cancer Netw. 16, 1362\u20131389. https:\/\/doi.org\/10.6004\/jnccn.2018.0083 (2018).","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"85899_CR12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.14694\/EDBK_100001","volume":"35","author":"ME Sabatini","year":"2016","unstructured":"Sabatini, M. E. & Ellisen, L. W. Womens health issues for BRCA mutation carriers. Am. Soc. Clin. Oncol. Educ. Book 35, 14\u201317. https:\/\/doi.org\/10.14694\/EDBK_100001 (2016).","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"85899_CR13","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1093\/jnci\/89.8.549","volume":"89","author":"JS Pankow","year":"1997","unstructured":"Pankow, J. S. et al. Genetic analysis of mammographic breast density in adult women: Evidence of a gene effect. J. Natl. Cancer Inst. 89, 549\u2013556. https:\/\/doi.org\/10.1093\/jnci\/89.8.549 (1997).","journal-title":"J. Natl. Cancer Inst."},{"key":"85899_CR14","doi-asserted-by":"publisher","first-page":"e1007757","DOI":"10.1371\/journal.pgen.1007757","volume":"14","author":"S Selzam","year":"2018","unstructured":"Selzam, S. et al. Evidence for gene-environment correlation in child feeding: Links between common genetic variation for BMI in children and parental feeding practices. PLoS Genet. 14, e1007757. https:\/\/doi.org\/10.1371\/journal.pgen.1007757 (2018).","journal-title":"PLoS Genet."},{"key":"85899_CR15","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1200\/JCO.2017.77.3424","volume":"36","author":"AS Reiner","year":"2018","unstructured":"Reiner, A. S. et al. Breast cancer family history and contralateral breast cancer risk in young women: An update from the Women\u2019s Environmental Cancer and Radiation Epidemiology Study. J. Clin. Oncol. 36, 1513\u20131520. https:\/\/doi.org\/10.1200\/JCO.2017.77.3424 (2018).","journal-title":"J. Clin. Oncol."},{"key":"85899_CR16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s13402-011-0010-3","volume":"34","author":"P van der Groep","year":"2011","unstructured":"van der Groep, P., van der Wall, E. & van Diest, P. J. Pathology of hereditary breast cancer. Cell Oncol. (Dordr) 34, 71\u201388. https:\/\/doi.org\/10.1007\/s13402-011-0010-3 (2011).","journal-title":"Cell Oncol. (Dordr)"},{"key":"85899_CR17","doi-asserted-by":"publisher","first-page":"e279","DOI":"10.1016\/S1470-2045(13)70567-9","volume":"15","author":"L Fan","year":"2014","unstructured":"Fan, L. et al. Breast cancer in China. Lancet Oncol. 15, e279-289. https:\/\/doi.org\/10.1016\/S1470-2045(13)70567-9 (2014).","journal-title":"Lancet Oncol."},{"key":"85899_CR18","unstructured":"Society, A. C. Cancer Facts and Figures 2020. (2020)."},{"key":"85899_CR19","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3322\/caac.21583","volume":"69","author":"CE DeSantis","year":"2019","unstructured":"DeSantis, C. E. et al. Breast cancer statistics, 2019. CA Cancer J. Clin. 69, 438\u2013451. https:\/\/doi.org\/10.3322\/caac.21583 (2019).","journal-title":"CA Cancer J. Clin."},{"key":"85899_CR20","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3322\/caac.21456","volume":"68","author":"LA Torre","year":"2018","unstructured":"Torre, L. A. et al. Ovarian cancer statistics, 2018. CA Cancer J. Clin. 68, 284\u2013296. https:\/\/doi.org\/10.3322\/caac.21456 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"85899_CR21","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.breast.2017.01.016","volume":"32","author":"JL Song","year":"2017","unstructured":"Song, J. L., Chen, C., Yuan, J. P., Li, J. J. & Sun, S. R. Family history of cancer other than breast or ovarian cancer in first-degree relatives is associated with poor breast cancer prognosis. Breast 32, 130\u2013134. https:\/\/doi.org\/10.1016\/j.breast.2017.01.016 (2017).","journal-title":"Breast"},{"key":"85899_CR22","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.breast.2012.08.005","volume":"22","author":"FP Turkoz","year":"2013","unstructured":"Turkoz, F. P. et al. Association between common risk factors and molecular subtypes in breast cancer patients. Breast 22, 344\u2013350. https:\/\/doi.org\/10.1016\/j.breast.2012.08.005 (2013).","journal-title":"Breast"},{"key":"85899_CR23","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s10552-017-0928-5","volume":"28","author":"AS Jannot","year":"2017","unstructured":"Jannot, A. S., Usel, M., Bouchardy, C., Schubert, H. & Rapiti, E. Breast cancer family history leads to early breast cancer detection and optimal management. Cancer Causes Control 28, 921\u2013928. https:\/\/doi.org\/10.1007\/s10552-017-0928-5 (2017).","journal-title":"Cancer Causes Control"},{"key":"85899_CR24","doi-asserted-by":"publisher","first-page":"664","DOI":"10.3389\/fonc.2018.00664","volume":"8","author":"C Santamaria-Ulloa","year":"2018","unstructured":"Santamaria-Ulloa, C. & Valverde-Manzanares, C. Inequality in the incidence of cervical cancer: Costa Rica 1980\u20132010. Front Oncol. 8, 664. https:\/\/doi.org\/10.3389\/fonc.2018.00664 (2018).","journal-title":"Front Oncol."},{"key":"85899_CR25","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/ijc.10342","volume":"99","author":"A Russo","year":"2002","unstructured":"Russo, A. et al. Does family history influence survival in breast cancer cases?. Int. J. Cancer 99, 427\u2013430. https:\/\/doi.org\/10.1002\/ijc.10342 (2002).","journal-title":"Int. J. Cancer"},{"key":"85899_CR26","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s10552-019-01171-5","volume":"30","author":"FS Albright","year":"2019","unstructured":"Albright, F. S. et al. Population-based relative risks for specific family history constellations of breast cancer. Cancer Causes Control 30, 581\u2013590. https:\/\/doi.org\/10.1007\/s10552-019-01171-5 (2019).","journal-title":"Cancer Causes Control"},{"key":"85899_CR27","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1002\/cncr.32815","volume":"126","author":"T Mukama","year":"2020","unstructured":"Mukama, T. et al. Familial risk of breast cancer by dynamic, accumulative, and static definitions of family history. Cancer 126, 2837\u20132848. https:\/\/doi.org\/10.1002\/cncr.32815 (2020).","journal-title":"Cancer"},{"key":"85899_CR28","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1158\/1055-9965.EPI-11-0781","volume":"20","author":"KE Malone","year":"2011","unstructured":"Malone, K. E. et al. Family history of breast cancer in relation to tumor characteristics and mortality in a population-based study of young women with invasive breast cancer. Cancer Epidemiol. Biomark. Prev. 20, 2560\u20132571. https:\/\/doi.org\/10.1158\/1055-9965.EPI-11-0781 (2011).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"85899_CR29","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou, A. et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: A combined analysis of 22 studies. Am. J. Hum. Genet. 72, 1117\u20131130. https:\/\/doi.org\/10.1086\/375033 (2003).","journal-title":"Am. J. Hum. Genet."},{"key":"85899_CR30","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/ng0596-126","volume":"13","author":"S Neuhausen","year":"1996","unstructured":"Neuhausen, S. et al. Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer. Nat. Genet. 13, 126\u2013128. https:\/\/doi.org\/10.1038\/ng0596-126 (1996).","journal-title":"Nat. Genet."},{"key":"85899_CR31","doi-asserted-by":"publisher","first-page":"920","DOI":"10.2214\/AJR.16.16957","volume":"209","author":"SM Ha","year":"2017","unstructured":"Ha, S. M. et al. Association of BRCA mutation types, imaging features, and pathologic findings in patients with breast cancer with BRCA1 and BRCA2 mutations. Am. J. Roentgenol. 209, 920\u2013928. https:\/\/doi.org\/10.2214\/AJR.16.16957 (2017).","journal-title":"Am. J. Roentgenol."},{"key":"85899_CR32","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.humpath.2018.10.005","volume":"84","author":"IMH Sonderstrup","year":"2019","unstructured":"Sonderstrup, I. M. H. et al. Subtypes in BRCA-mutated breast cancer. Hum. Pathol. 84, 192\u2013201. https:\/\/doi.org\/10.1016\/j.humpath.2018.10.005 (2019).","journal-title":"Hum. Pathol."},{"issue":"102\u2013107","key":"85899_CR33","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1159\/000475698","volume":"12","author":"M Gnant","year":"2017","unstructured":"Gnant, M., Harbeck, N., Thomssen, C. S. & Gallen, V. A brief summary of the consensus discussion about escalation and de-escalation of primary breast cancer treatment. Breast Care (Basel) 12(102\u2013107), 2017. https:\/\/doi.org\/10.1159\/000475698 (2017).","journal-title":"Breast Care (Basel)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-85899-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-85899-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-85899-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T00:37:56Z","timestamp":1670027876000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-85899-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,18]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["85899"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-85899-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,18]]},"assertion":[{"value":"15 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6360"}}